For research use only. Not for therapeutic Use.
Nardosinone, isolated from Nardostachys chinensis, is the first enhancer of the neuritogenic action of dbcAMP and staurosporine. Nardosinone may become a useful pharmacological tool for studying the mechanism of action of not only nerve growth factor (NGF) but also both the neuritogenic substances[1].
Nardosinone (0.1-100 microM) enhanced dibutyryl cyclic AMP (dbcAMP, 0.3 mM)- and staurosporine (10 nM)-induced neurite outgrowth from PC12D cells in a concentration-dependent manner. Nardosinone enhances a downstream step of MAP kinase in the MAP kinase-dependent signaling pathway[1].
| Catalog Number | R014942 |
| CAS Number | 23720-80-1 |
| Synonyms | (3aR,9R,9aR,9bS)-1,1,9,9a-tetramethyl-3a,4,7,8,9,9b-hexahydronaphtho[2,1-c]dioxol-5-one |
| Molecular Formula | C15H22O3 |
| Purity | ≥95% |
| InChI | InChI=1S/C15H22O3/c1-9-6-5-7-10-11(16)8-12-13(15(9,10)4)14(2,3)18-17-12/h7,9,12-13H,5-6,8H2,1-4H3/t9-,12-,13+,15+/m1/s1 |
| InChIKey | KXGHHSIMRWPVQM-JWFUOXDNSA-N |
| SMILES | CC1CCC=C2C1(C3C(CC2=O)OOC3(C)C)C |
| Reference | [1]. Li P, et al. Nardosinone, the first enhancer of neurite outgrowth-promoting activity of staurosporine and dibutyryl cyclic AMP in PC12D cells.Brain Res Dev Brain Res. 2003 Nov 12;145(2):177-83. |
